Tag: Europe
-
Alzheimer’s Vaccine Shown to Produce Immune Response
In tests with lab animals, an experimental vaccine is shown to generate antibodies responding to toxic brain proteins associated with Alzheimer’s disease.
-
Science/Tech AI Developer Raises $100M in New Funds
A provider of artificial intelligence services for scientific and advanced technology applications is raising $100 million in its second venture round.
-
Group Devising Lower Cost Clinical Trials
A new not-for-profit organization aims to create a more efficient process for large-scale randomized clinical trials, to provide reliable results at lower cost.
-
Infographic – Venture Funds More Than Double in 2021
Venture funding worldwide rose sharply in 2021, with investment dollars climbing to nearly $621 billion, more than twice the total invested in 2020.
-
Trial Shows Gut Probiotic Reduces Covid-19 Disease
Results of a clinical trial show a microbial supplement in the gut reduces respiratory symptoms and viral load in people with mild Covid-19 disease.
-
Biotech, AI Company Partner on Covid-19 Alert System
A developer of Covid-19 vaccines and an artificial intelligence company are building a system to quickly detect dangerous SARS-CoV-2 variants.
-
Sanofi Partners in $5.3B Precision Drug Discovery Deal
A company using artificial intelligence to design drugs for personalized treatments is partnering with drug maker Sanofi in a deal valued at $5.3 billion.
-
Trial Set for Covid-19 Nasal Spray Vaccine
A clinical trial testing a vaccine to protect against Covid-19 disease, given as a nasal spray, is scheduled to begin later this year in the Netherlands.
-
Trial Underway Testing PTSD Drug Therapy
A clinical trial is underway testing an experimental drug to treat the underlying causes and symptoms of post-traumatic stress disorder or PTSD.
-
CEPI Funds Multi-Variant Covid-19 Vaccine
Coalition for Epidemic Preparedness Innovations or CEPI is funding a new vaccine to protect against emerging Covid-19 variants and other coronaviruses.